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Background: Myosin IC is a single headed member of the myosin superfamily that localizes to the cytoplasm
and the nucleus and is implicated in a variety of processes in both compartments. We recently identified a novel
isoform of myosin IC and showed that the MYOIC gene in mammalian cells encodes three isoforms (isoforms A, B,
and C) that differ only in the addition of short isoform-specific N-terminal peptides. The expression pattern of the
isoforms and the mechanisms of expression regulation remain unknown.
Results: To determine the expression patterns of myosin IC isoforms, we performed a comprehensive expression
analysis of the two myosin IC isoforms (isoform A and B) that contain isoform-specific sequences. By immunoblotting
with isoform-specific antibodies and by qRT-PCR with isoform-specific primer we demonstrate that myosin IC isoforms
A and B have distinct expression patterns in mouse tissues. Specifically, we show that myosin IC isoform A is expressed
in a tissue specific pattern, while myosin IC isoform B is ubiquitously expressed at comparable levels in mouse tissues.
Conclusions: The differences in the expression profile of the myosin IC isoforms indicate a tissue-specific MYOIC
gene regulation and further suggest that the myosin IC isoforms, despite their high sequence homology, might
have tissue-specific and isoform-specific functions.
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Myosin IC (formerly known as myosin I-β; [1]) is a single
headed class I myosin that localizes to the nucleus and the
cytoplasm. In the cytoplasm, myosin IC has been impli-
cated, among other processes, in lipid raft arrangements
[2], transport of vesicles containing membrane proteins
such as the glucose transporter [3], and in ion channel
regulation in hair cells of the inner ear [4-6]. In the
nucleus, myosin IC is involved in various aspects of
transcription [7-10], in chromatin remodeling [11-13], and
in dynamic organization of chromosomal structures [14].
Initially, it was thought that the cytoplasmic and nuclear
functions of myosin IC are facilitated by two isoforms that
are encoded by the MYOIC gene, known as myosin IC
and nuclear myosin I (NMI) [9,15]. However, a number of
recent studies showed that both isoforms can localize
to the cytoplasm and the nucleus [16,17]. In addition,
we recently identified a previously unknown isoform of
myosin IC and demonstrated that the MYOIC gene in
mammalian cells encodes three isoforms: isoform A
(newly discovered [18]), B (formerly NMI [9,15]), and C* Correspondence: whofmann@buffalo.edu
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unless otherwise stated.(formerly known as myosin IC [19]). As shown in Figure 1,
the only difference between the three isoforms are add-
itional, short N-terminal peptide sequences of 35 and
16 amino acids that are added to isoforms A and B re-
spectively that are derived from upstream exons [18].
Interestingly, despite the high sequence homology, initial
studies on isoform localization and function indicate
that the myosin IC isoforms localize to different cellular
compartments and are functionally distinct [17,18]. How-
ever, the underlying factors that facilitate the functional
difference between the isoforms are not fully understood.
In addition to the potential functional differences between
the isoforms and their distinct intracellular localizations,
our previous analysis of expression of the newly identified
myosin IC isoform A in tissue culture cells also indicated
a potential difference in expression patterns between the
isoforms [18].
Previous studies analyzing expression of total myosin
IC with antibodies directed against an epitope in the C-
terminal domain that is common to all myosins as well
as studies analyzing protein and mRNA expression of
myosin IC isoform B (NMI) in a variety of organisms and
tissues demonstrated a ubiquitous and conserved expres-
sion of myosin IC [20-22]. However, our comparison oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Schematic of myosin IC isoform-specific sequences and
recognition site of antibodies. The upper panel depicts the 5’ region
of the mammalian myosin IC gene including the exons that code for
isoform-specific N-terminal peptides and the transcription initiation sites
for the isoforms. The lower panel shows the N-terminal amino acid
sequences of the isoforms. Underlined are the peptide sequences that
were used as immunogen to create isoform-specific antibodies [9,18].
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and NIH 3T3 cells showed that while all three cell types
express myosin IC isoform B at comparable levels, isoform
A was strongly expressed only in COS-7 cells but could
barely be detected in NIH 3T3 and HeLa cells [18] which
suggests a difference in the expression pattern of the
myosin IC isoforms. Therefore, we extended our studies
and present here a comprehensive analysis of the
expression pattern of myosin IC isoform A and B in
mouse organs and tissues.
Results and discussion
As shown in Figure 1, only two of the three myosin IC
isoforms that are expressed by the MYOIC gene, namely
isoforms A and B, contain nucleotide and amino acid
sequences that are isoform-specific and thus can be de-
tected individually [18]. To determine protein expression
of the two isoforms, we performed immunoblot analysis
of a panel of 33 different organs and tissues that were
collected from 2-4 month old male and female C57Bl/6
mice. Protein extracts were analyzed using antibodies
that recognize the individual isoforms. Figure 1 shows a
schematic of the 5’ region of MYOIC, the resulting N-
terminal amino acid sequences of the myosin IC isoforms,
and the amino acid sequences that are recognized by the
isoform-specific antibodies. The antibody that recognizes
specifically myosin IC isoform A, is a monoclonal anti-
body that was generated using a peptide sequence that is
encoded by the isoform A-specific exon −2 as immunogen
[18]. The antibody that recognizes myosin IC isoform B
(NMI) is a polyclonal antibody that was generated using
the isoform B-specific 16 amino acid long N-terminal
peptide as immunogen [9].
Probing the organ and tissue extracts with the myosin
IC isoform A-specific antibody (Figure 2A and B) showed
that isoform A is expressed in a tissue-specific pattern.
Expression levels are high in kidney, adrenal gland,
pancreas, and in a subset of adipose tissues, specifically
in tissue from epididymal and retroperitoneal adiposedepots. In addition, moderate levels of isoform A protein
can be consistently detected with only slight variations,
in protein extracts from liver, spleen, ovaries, and tissue
from mesenteric, inguinal, and white subscapular adi-
pose depots. In the remaining 22 analyzed organs and
tissues isoform A protein is only present at minimal,
barely detectable levels.
In contrast to the tissue-specific expression of isoform
A, myosin IC isoform B protein is easily detectable in all
analyzed tissues and shows only moderate variations in
expression levels, with the lowest expression observed
in skeletal muscle and heart and the highest expression
observed in liver, thymus, and in the various adipose
depot tissues (Figure 2A and C). However, it should be
noted that the maximum difference in relative expression
of isoform B between the analyzed tissues is only 2.3 fold
while the difference in relative expression of isoform A
between the various tissues is up to 22 fold (compare
Figure 2B and C).
We next analyzed if this difference in expression patterns
between myosin IC isoforms A and B is also observed
on mRNA level. We measured mRNA expression of the
isoforms by quantitative real time PCR (qRT-PCR) using
isoform-specific forward primer and reverse primer that
bind to a region common to both isoforms. The location
of the primer is shown in Figure 3A. We found that the
mRNA expression profiles of myosin IC isoforms A and B
correlate to the protein expression profiles indicating
that regulation of expression takes place on gene level.
Comparable to the protein data, mRNA expression of
myosin IC isoform A is high in kidney, adrenal gland,
pancreas, and in adipose tissue from epididymal and
retroperitoneal depots. In addition, moderate levels of
isoform A mRNA are expressed in liver, spleen, ovaries,
and adipose tissue from mesenteric, inguinal, and sub-
scapular white fat depots. In the remaining 22 analyzed
organs and tissues isoform A mRNA can barely be detected
(Figure 3B).
In contrast, isoform B mRNA is expressed in all ana-
lyzed tissues with only slight variations in expression
levels (Figure 3C).
In summary, we have identified and characterized a
tissue-specific expression pattern of a recently identified,
novel myosin IC isoform and we demonstrate that two
of the myosin IC isoforms exhibit substantial differences
in the expression profiles. Our data show that in contrast
to the ubiquitously expressed myosin IC isoform B, the
newly discovered myosin IC isoform A exhibits tissue-
specific expression patterns on both, protein and mRNA
levels. Previous studies analyzing the cellular distribution
of the myosin IC isoforms in COS-7 cells, i.e. in a cell line
that expresses all three myosin IC isoforms at high levels
[18], revealed that each of the three isoforms localizes
to specific cellular regions and interacts with different
Figure 2 Protein expression of myosin IC isoforms A and B in mouse tissues. Detection of myosin IC isoforms A and B in various mouse
tissues by immunoblot analysis using antibodies specific to myosin IC isoforms A, isoform B, and actin (control). A) Representative immunoblots of
mouse tissue extracts that were analyzed using the indicated antibodies. Relevant molecular weight markers are indicated on the left. B) Histogram
presenting the average densitometric intensity of isoform A expression normalized to actin. C) Histogram presenting the average densitometric
intensity of isoform B expression normalized to actin. Results are presented as means + standard deviation; n = 3-6 (depending on tissue type).
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specific cellular functions. Our identification of differen-
tial expression profiles further strengthens the notion that
the myosin IC isoforms are functionally distinct. Future
work is aimed at understanding the regulatory mecha-
nisms that lead to tissue-specific expression of myosin
IC isoform A and at identifying potential tissue-specific
functions of this isoform.
Conclusions
The MYOIC gene expresses three different isoforms two of
which exhibit significant differences in expression patterns.
While myosin IC isoform B is ubiquitously expressed,




Figure 1 shows the isoform-specific sequences that were
used to generate myosin IC isoform specific antibodies.
Antibodies that recognize various isoforms of myosin
IC are: 1. the anti-NMI antibody is a rabbit polyclonal
antibody that was raised against the 16 amino acid long
N-terminal peptide of NMI, here called isoform B [9,23]
(Sigma-Aldrich, St Louis, MO); 2. the myosin IC-isoform
A antibody is a mouse monoclonal antibody that was
raised against the myosin IC isoform A specific N-
Figure 3 mRNA expression of myosin IC isoforms A and B in mouse tissues. A) Schematic depicting the 5’ region of the MYOIC gene and
the resulting mRNA structure. The target sequence region and location of primer used for qRT-PCR to detect myosin IC isoforms A and B
are indicated by arrows. B) Quantitative real-time PCR analysis of mRNAs expression levels of myosin IC isoform A normalized to GAPDH. C)
Quantitative real-time PCR analysis of mRNAs expression levels of myosin IC isoform B normalized to GAPDH. Results are presented as means
+ standard deviation; n =3-6 (depending on tissue type).
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isoform A [18]. Monoclonal antibodies to β-actin were
obtained from Sigma (Sigma-Aldrich, St Louis, MO).
Peroxidase-conjugated secondary anti–mouse or anti–
rabbit antibodies were obtained from Jackson Immu-
noResearch Laboratories (West Grove, PA).Table 1 Primer used in qRT-PCR analysis
Gene Forward primer (5’-3’) Reverse primer (5’-3’)
MYOIC (isoform A) ggagagatcatccgtgtggt ggaccgatgtaggtataaatgagg
MYOIC (isoform B) gcgctaccgggcatcg ggaccgatgtaggtataaatgagg
GAPDH ggtgaaggtcggtgtgaacg ctcgctcctggaagatggtgAnimals and tissue collection
Tissue was isolated from male and female C57BL/6 mice
2–4 month old. All animal work was approved by the
institutional animal care and use committee (University
at Buffalo; protocol # PGY58128N). For each tissue type,
tissues were extracted and analyzed from at least 3 male
and 3 female mice.
Immunoblot analysis
For preparation of protein extracts, tissues were homog-
enized by sonication at 4°C for 5–20 seconds (depending
on tissue) in extraction buffer [1x PBS, 1% NP40; 5 mM
EDTA; 2% SDS, 1% Na-deoxycholate, with protease
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30 min incubation on a rocking platform at 4°C. The
samples were then centrifuged at maximum speed in a
tabletop centrifuge for 10 min at room temperature. The
supernatant was used to determine protein concentration
using a Bradford protein assay according to manufacturer’s
instructions (Bio-Rad, Hercules, CA). Equal amounts of
protein extracts (40 μg) were separated by 10% SDS-PAGE
(sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis) and transferred onto nitrocellulose membrane. After
transfer, the membrane was cut followed by incubation
of the lower half with antibodies specific to actin while
the upper half was incubated with antibodies specific to
myosin IC isoform A. Immunoreactive bands were de-
tected by enhanced chemiluminescence. After detection
of isoform A, the blots were stripped and re-probed with
the antibody specific to myosin IC isoform B. Densito-
metric analysis was performed on the selected bands based
on their relative intensities using ImageJ software.Quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from mouse tissues using Trizol®
reagent (Invitrogen, Carlsbad, CA) following the manufac-
turer’s instructions. 1 μg total RNA from each tissue sample
was used to reverse transcribe into cDNA using Superscript
III reverse transcriptase and oligo dT primer according
to manufacturer’s instructions (Invitrogen, Carlsbad, CA).
qRT-PCR was performed using the iCycler iQ Real-Time
PCR Detection System (Bio-Rad, Hercules, CA) and pri-
mer that are indicated below that recognize specifically
myosin IC isoform A (homo sapiens: NM_033375.4;
mus musculus: XM_006532429.1) and myosin IC isoform
B (homo sapiens: NM_001080950.1; mus musculus:
NM_001080775). For quantification, triplicates were nor-
malized to the average of the GAPDH housekeeping gene.
For verification of sequences, the qRT-PCR product were
separated on a 2% agarose gel, isolated from the gel and
sent for DNA sequencing. Table 1 shows the primer used
in qRT-PCR to detect isoform-specific expression levels
of myosin IC isoforms A and B (see also schematic in
Figure 3A).
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